HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Self-remitting Elevation of Adenosine Deaminase Levels in the Cerebrospinal Fluid with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report and Review of the Literature.

Abstract
A 29-year-old man presented with a high-grade fever, headache, and urinary retention, in addition to meningeal irritation and myoclonus in his upper extremities. A cerebrospinal fluid (CSF) examination showed pleocytosis and high adenosine deaminase (ADA) levels with no evidence of bacterial infection, including Mycobacterium tuberculosis. T2-weighted brain magnetic resonance imaging showed transient hyper-intensity lesions at the splenium of the corpus callosum (SCC), bilateral putamen, and pons during the course of the disease. The CSF was positive for anti-glial fibrillary acidic protein (GFAP) antibodies. He was diagnosed with autoimmune GFAP astrocytopathy. The present case shows that the combination of an elevated ADA level in the CSF and reversible T2-weighted hyper-intensity on the SCC supports the diagnosis of autoimmune GFAP encephalopathy.
AuthorsSota Nakamura, Teppei Fujioka, Shoji Kawashima, Takatsune Kawaguchi, Masayuki Mizuno, Masahiro Omura, Kenji Okita, Akio Kimura, Takayoshi Shimohata, Noriyuki Matsukawa
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 60 Issue 18 Pg. 3031-3036 (Sep 15 2021) ISSN: 1349-7235 [Electronic] Japan
PMID33814491 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Autoantibodies
  • Glial Fibrillary Acidic Protein
  • Adenosine Deaminase
Topics
  • Adenosine Deaminase
  • Adult
  • Astrocytes
  • Autoantibodies
  • Encephalitis
  • Glial Fibrillary Acidic Protein
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: